E9-30868. National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, “Ancillary Studies in Immunomodulation Clinical Trials.”

    Date: January 19, 2010.

    Time: 1 p.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817. (Telephone Conference Call.)

    Contact Person: Paul A. Amstad, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616. 301-402-7098. pamstad@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, “Immunobiology of Mesenchymal Stem Cells.”

    Date: January 26, 2010.

    Time: 1 p.m. to 4 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817. (Telephone Conference Call.)

    Contact Person: Maryam Feili-Hariri, PhD, Scientific Review Officer, Immunology Review Branch, Scientific Review Program, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616. 301-402-5658. haririmf@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Atopic Dermatitis Research Network (ADRN).

    Date: February 2, 2010.

    Time: 8 a.m. to 12 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: Marriott Renaissance M Street Hotel, 1143 New Hampshire Avenue, NW., Washington, DC 20037.

    Contact Person: Paul A. Amstad, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616. 301-402-7098. pamstad@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Atopic Dermatitis Research Network: Statistical and Clinical Coordinating Center (ADRN SACCC).

    Date: February 2, 2010.

    Time: 12 p.m. to 6 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: Marriott Renaissance M Street Hotel, 1143 New Hampshire Avenue, NW., Potomac Room, Washington, DC 20037.

    Contact Person: Paul A. Amstad, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616. 301-402-7098. pamstad@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Highly Innovative Tactics to Interrupt Transmission of HIV (HIT-IT).

    Date: February 4-5, 2010.

    Time: 8 a.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Waterford Suite, Bethesda, MD 20814.

    Contact Person: Betty Poon, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616. 301-402-6891. poonb@mail.nih.ogv.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

    Start Signature

    Dated: December 22, 2009.

    Jennifer Spaeth,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. E9-30868 Filed 12-29-09; 8:45 am]

    BILLING CODE 4140-01-P